It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Although Krüppel-associated box domain-containing zinc-finger proteins (K-ZNFs) may be associated with sophisticated gene regulation in higher organisms, the physiological functions of most K-ZNFs remain unknown. The Zfp212 protein was highly conserved in mammals and abundant in the brain; it was mainly expressed in the cerebellum (Cb). Zfp212 (mouse homolog of human ZNF212) knockout (Zfp212-KO) mice showed a reduction in survival rate compared to wild-type mice after 20 months of age. GABAergic Purkinje cell degeneration in the Cb and aberrant locomotion were observed in adult Zfp212-KO mice. To identify genes related to the ataxia-like phenotype of Zfp212-KO mice, 39 ataxia-associated genes in the Cb were monitored. Substantial alterations in the expression of ataxin 10, protein phosphatase 2 regulatory subunit beta, protein kinase C gamma, and phospholipase D3 (Pld3) were observed. Among them, Pld3 alone was tightly regulated by Flag-tagged ZNF212 overexpression or Zfp212 knockdown in the HT22 cell line. The Cyclic Amplification and Selection of Targets assay identified the TATTTC sequence as a recognition motif of ZNF212, and these motifs occurred in both human and mouse PLD3 gene promoters. Adeno-associated virus-mediated introduction of human ZNF212 into the Cb of 3-week-old Zfp212-KO mice prevented Purkinje cell death and motor behavioral deficits. We confirmed the reduction of Zfp212 and Pld3 in the Cb of an alcohol-induced cerebellar degeneration mouse model, suggesting that the ZNF212–PLD3 relationship is important for Purkinje cell survival.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Sungkyunkwan University School of Medicine, Department of Pharmacology, Samsung Biomedical Research Institute, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); Sungkyunkwan University School of Medicine, Single Cell Network Research Center, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X)
2 Sungkyunkwan University School of Medicine, Laboratory Animal Research Center, Samsung Biomedical Research Institute, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); ToolGen, Seoul, South Korea (GRID:grid.410909.5)
3 Sungkyunkwan University, School of Pharmacy, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X)
4 Sungkyunkwan University, School of Pharmacy, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); Sungkyunkwan University, Biomedical Institute for Convergence, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X)
5 Sungkyunkwan University School of Medicine, Single Cell Network Research Center, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); Sungkyunkwan University School of Medicine, Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X)
6 Sungkyunkwan University School of Medicine, Single Cell Network Research Center, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); Sungkyunkwan University School of Medicine, Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, South Korea (GRID:grid.414964.a) (ISNI:0000 0001 0640 5613)
7 Sungkyunkwan University School of Medicine, Department of Pharmacology, Samsung Biomedical Research Institute, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, South Korea (GRID:grid.414964.a) (ISNI:0000 0001 0640 5613)
8 Sungkyunkwan University School of Medicine, Department of Pharmacology, Samsung Biomedical Research Institute, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); Sungkyunkwan University School of Medicine, Single Cell Network Research Center, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, South Korea (GRID:grid.414964.a) (ISNI:0000 0001 0640 5613)